Weill Cornell Mantle Cell Lymphoma (MCL) Research
The Weill Cornell Medicine Lymphoma Program has dedicated mantle cell lymphoma (MCL) expertise with a research initiative specifically focused on understanding the causes of MCL and developing the best mantle cell lymphoma treatments based on the scientific mechanisms and genetics driving the disease. Based on the nature of the disease, many people with MCL require repeated therapies. At Weill Cornell, our team brings a skill, depth and innovation to MCL research and care, offering clinical trials for patients in virtually every setting – older patients, younger patients, more intense treatments and less intense therapies – in order to help people live longer and improve the lives of those dealing with mantle cell lymphoma.